| Literature DB >> 33790026 |
Naofumi Ito1,2, M Asrafuzzaman Riyadh1,2,3, Shah Adil Ishtiyaq Ahmad1,2,4, Satoko Hattori5, Yonehiro Kanemura6, Hiroshi Kiyonari7, Takaya Abe7, Yasuhide Furuta7,8, Yohei Shinmyo1,2,9, Naoko Kaneko10, Yuki Hirota10,11, Giuseppe Lupo12, Jun Hatakeyama13, Felemban Athary Abdulhaleem M1,2,14, Mohammad Badrul Anam1,2,15, Masahiro Yamaguchi16, Toru Takeo17, Hirohide Takebayashi18, Minoru Takebayashi19, Yuichi Oike20, Naomi Nakagata17, Kenji Shimamura13, Michael J Holtzman21, Yoshiko Takahashi22,23, Francois Guillemot24, Tsuyoshi Miyakawa5, Kazunobu Sawamoto10,25, Kunimasa Ohta26,2,15,23,27.
Abstract
The lateral ventricle (LV) is flanked by the subventricular zone (SVZ), a neural stem cell (NSC) niche rich in extrinsic growth factors regulating NSC maintenance, proliferation, and neuronal differentiation. Dysregulation of the SVZ niche causes LV expansion, a condition known as hydrocephalus; however, the underlying pathological mechanisms are unclear. We show that deficiency of the proteoglycan Tsukushi (TSK) in ependymal cells at the LV surface and in the cerebrospinal fluid results in hydrocephalus with neurodevelopmental disorder-like symptoms in mice. These symptoms are accompanied by altered differentiation and survival of the NSC lineage, disrupted ependymal structure, and dysregulated Wnt signaling. Multiple TSK variants found in patients with hydrocephalus exhibit reduced physiological activity in mice in vivo and in vitro. Administration of wild-type TSK protein or Wnt antagonists, but not of hydrocephalus-related TSK variants, in the LV of TSK knockout mice prevented hydrocephalus and preserved SVZ neurogenesis. These observations suggest that TSK plays a crucial role as a niche molecule modulating the fate of SVZ NSCs and point to TSK as a candidate for the diagnosis and therapy of hydrocephalus.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33790026 DOI: 10.1126/scitranslmed.aay7896
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956